Lyell Immunopharma, Inc. (LYEL)

26.59 +4.13 (+18.39%) USD  |  NASDAQ  |  Mar 09, 13:57
More

Lyell Immunopharma Income Tax Paid Supplemental Data (Quarterly)

Income Tax Paid Supplemental Data (Quarterly) Chart

View Income Tax Paid Supplemental Data (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Income Tax Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Income Tax Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Income Tax Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Income Tax Paid Supplemental Data (Quarterly) Benchmarks

View Income Tax Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade